21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Capsid inhibitors for the treatment of HIV
#7202Neprilysin inhibitors
#7203MCL-1 inhibitors
#7204SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF
#7205Phase Change Material for Thermal Therapy and Delivery of Active Ingredients
#7206COMBINATION THERAPY WITH ANTI-TROP-2 ANTIBODIES AND PARP INHIBITORS
#7207OPHTHALMIC COMPOSITIONS
#7208ANTI-VIRAL COMPOSITION AND METHOD FOR PREPARING THE SAME
#7209Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids
#7210USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
#7211CDKN2A companion diagnostic for bladder cancer interferon therapy
#7212EPIGENETIC MODIFIERS TO TREAT RETINAL DEGENERATIONS
#7213PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF
#7214TISSUE REPAIR AND WOUND HEALING COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT HYDROLYZED COLLAGEN
#7215ORAL RINSE FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH
#7216DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS
#7217LACTOBACILLUS PLANTARUM MICROORGANISMS HAVING ANTI-CANCER ACTIVITY, COMPOSITION INCLUDING SAME, AND METHOD FOR PREVENTING OR TREATING CANCER USING SAME
#7218COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING
#7219USE OF ADLERCREUTZIA BACTERIA FOR THE TREATMENT OF INFLAMMATORY DISEASES
#7220HEMATOPOIETIC STEM CELL ENGRAFTMENT WITH A COMBINATION OF AGENTS
#7221PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + MOLNUPIRAVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19
#7222METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY HYPERTENSION AND CANCER
#7223TREATMENT FOR SCHIZOPHRENIA
#7224VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS
#7225TTP phosphorylation for the identification of personalized medicines
#7226HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
#7227MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
#7228METHODS AND COMPOSITIONS FOR HYPOTENSIVE RESUSCITATION
#7229METHODS FOR TREATING HYPERCHOLESTEROLEMIA
#7230CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS
#7231Topical roflumilast formulation having improved delivery and plasma half-life
#7232Method of improving psychosocial health
#7233METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#7234CO-THERAPIES INCLUDING A METASTASIS INHIBITOR
#7235METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#7236Compositions And Methods For Treating Autism
#7237USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER
#7238ANTIFUNGAL PROPHYLAXIS FOR CORNEA
#7239Method of Plant-Based Inhalation for the Treatment of Respiratory Viruses
#7240Tamper resistant dosage forms
#7241High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#7242CULTIVATION OF PLACENTA TO ISOLATE EXOSOMES
#7243DELIVERY SYSTEM
#7244AGGLOMERATED BOTANICAL MATERIAL FOR ORAL PRODUCTS
#7245COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS
#7246ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC PRODUCTS
#7247METHODS OF TREATING GLIOBLASTOMA
#7248Anti-Notch2 Antibodies and Methods of Use
#7249PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE
#7250MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF
#7251N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF
#7252IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF
#7253RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF
#7254CELL ACTIVATABLE IRON CHELATORS
#7255INHIBITORS OF ACK1/TNK2 TYROSINE KINASE
#7256Crystalline freebase forms of a biphenyl compound
#7257DR5 RADIOIMMUNOTHERAPY IN THE TREATMENT OF SOLID CANCERS
#7258RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF CANCERS
#7259ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF
#7260Porphyrin Compounds and Compositions Useful for Treating Cancer
#7261Multiple sign bit hiding within a transform unit
#7262Recombinant RSV with silent mutations, vaccines, and methods related thereto
#7263SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
#7264Combination Therapy with Controlled-Release CNP Agonists
#7265AGENT FOR REVERSIBLE OPENING OF NEURAL VASCULAR BARRIER
#7266AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM
#7267REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE
#7268Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome
#7269BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM
#7270COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS
#7271N'-(2-CHLORO-6-METHYLBENZOYL)-4-METHYL-3-[2-(3-QUINOLYL)ETHYNYL]-BENZOHYDRAZIDE FOR TREATMENT OF ALZHEIMER'S DISEASE
#7272TLR7/8 ANTAGONISTS AND USES THEREOF
#7273COMBINATIONS FOR THE TREATMENT OF CANCER
#7274TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
#7275METHOD OF ENHANCING 5-HYDROXYTRYPTOPHAN (5-HTP) EXPOSURE
#7276A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy
#7277METHOD FOR SELECTING CANCER PATIENTS FOR WHOM COMBINATION THERAPY WITH RETINOID AND CANCER THERAPEUTIC AGENT IS EFFECTIVE, AND COMBINATION MEDICAMENT WITH RETINOID AND CANCER THERAPEUTIC AGENT
#7278AMINOXY ACID-BASED ANTI-CANCER STEM CELL COMPOUNDS AND METHODS THEREOF
#7279Use of cannabinoids in the treatment of epilepsy
#7280Use of cannabidiol in the treatment of tuberous sclerosis complex
#7281NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER
#7282Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#7283Layered Pharmaceutical Formulations
#7284Hollow silica spheres with nested iron oxide particles
#7285USE OF GENE INVOLVED IN PASSAGE THROUGH BRAIN-BLOOD BARRIER AND SURVIVAL INSIDE BRAIN OF CAUSATIVE FUNGI OF MENINGOENCEPHALITIS
#7286PREDICTING ADVERSE EVENTS FROM IMMUNOTHERAPY
#7287CLASSIFYING TUMORS AND PREDICTING RESPONSIVENESS
#7288METHODS FOR DIAGNOSING AND TREATING AUTISM
#7289COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#7290METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION
#7291MICRORNAS AND METHODS OF THEIR USE
#7292PH20 polypeptide variants, formulations and uses thereof
#7293PH20 polypeptide variants, formulations and uses thereof
#7294SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS
#7295ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER
#7296MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT
#7297OX40-TARGETED ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#7298METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L
#7299ANTIBODIES SPECIFIC TO DELTA 1 CHAIN OF T CELL RECEPTOR
#7300HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER
#7301METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT
#7302NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPY
#7303ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIES
#7304Chimeric inhibitor molecules of complement activation
#7305ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS
#7306FUSED HETEROAROMATIC PYRROLIDINONES
#7307CRYSTALLINE FORMS OF 4-[(7-CHLORO-2-METHOXYBENZO[B][1,5]NAPHTHYRIDIN-10-YL)AMINO]-2,6-BIS(PYRROLIDIN-1-YLMETHYL)PHENOL AND SALTS THEREOF
#7308MONOBACTAM COMPOUNDS, THEIR PREPARATION AND USE AS ANTIBACTERIAL AGENTS
#7309INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4
#7310Process for preparing a compound useful to treat mycoses
#7311INHIBITORS OF ACK1/TNK2 TYROSINE KINASE
#7312SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#7313SUBSTITUTED ISOQUINOLINYLMETHYL AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#7314HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
#7315CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF
#7316Compositions and Methods for Tendon Regeneration
#7317Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
#7318METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS
#7319COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#7320BRK PEPTIDES AND METHODS OF USE
#7321METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN
#7322SAUVIGNON BLANC GRAPE SEED PRODUCTS FOR NONALCOHOLIC FATTY LIVER DISEASE
#7323COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES
#7324COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION
#7325TARGETING OF SRC-3 IN IMMUNE CELLS AS AN IMMUNOMODULATORY THERAPEUTIC FOR THE TREATMENT OF CANCER
#7326PD1-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AS AN IMMUNOTHERAPY
#7327TREATMENT OF BACTERIAL VAGINOSIS
#7328OHPP-FORMULATED NICLOSAMIDE TO TREAT SARS-COV-2, OTHER VIRAL DISEASES, AND CANCERS
#7329Product and method for increasing uridine concentration in blood plasma
#7330N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto
#7331METHOD OF PREVENTING, REDUCING OR DELAYING FATTY LIVER DISEASE
#7332INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CYCLODEXTRIN, A HYDROPHOBIC DRUG, A CO-SOLVENT AND A PRESERVATIVE
#7333INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS
#7334FENOLDOPAM TOPICAL FORMULATIONS FOR TREATING SKIN DISORDERS
#7335USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#7336METHOD FOR TREATING CANCER WITH A REVERSE TRANSCRIPTASE INHIBITOR
#7337SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
#7338S100 PROTEINS AS NOVEL THERAPEUTIC TARGETS IN MYELOPROLIFERATIVE NEOPLASMS
#7339METHOD AND COMPOUND FOR USE, IN TREATING AND/OR PREVENTING NETOSIS
#7340Methods and compositions for treatment of epileptic disorders
#7341Methods and compositions for treatment of epileptic disorders
#7342COMPOSITIONS AND METHODS OF USE OF ANTIBACTERIAL DRUG COMBINATIONS
#7343Determination of personalized endocannabinoid genotypes and associated recommendations
#7344NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN ACUTE MYELOID LEUKEMIA
#7345Methods of identifying and treating patients with HIF-2 inhibitor resistance
#7346USE OF APE1/REF-1 INHIBITORS FOR TREATMENT OF RETINAL DISEASES
#7347NOVEL PHARMACEUTICAL COMPOSITIONS
#7348KRAS agonists, pharmaceutical compositions, and uses in managing cancer
#7349TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA WITH MIRDAMETINIB
#7350Treatment of cutaneous neurofibromas with Mirdametinib
#7351METHOD FOR TREATING DERMATITIS
#7352MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
#7353RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES
#7354STIMULATION OF HAIR GROWTH
#7355IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
#7356Composition and method for treatment of neuropsychiatric disorders
#7357SPRAY DRYING OF SUPERSATURATED SOLUTIONS OF API WITH ACETIC ACID
#7358Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols
#7359Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection
#7360APPLICATION OF COMPOUNDS IN THE PREPARATION OF REAGENTS FOR DOWN-REGULATION OF RUNX2
#7361COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA
#7362METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#7363PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#7364METHODS OF TREATING OR REDUCING RISK OF TRANSPLANT REJECTION
#7365ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE
#7366MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF
#7367NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE
#7368METHODS FOR TREATING ATOPIC DERMATITIS AND RELATED DISORDERS
#7369POLYPEPTIDES
#7370TGF-β3 specific antibodies and methods and uses thereof
#7371HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS)
#7372C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS
#7373OXO-SUBSTITUTED COMPOUND
#7374Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
#7375NEW PqsR INVERSE AGONISTS
#7376SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE
#7377ISOQUINOLINE DERIVATIVES FOR USE IN THERAPY
#7378Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms
#7379INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF
#7380COMPOSITIONS AND METHODS FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DISEASE
#7381METHODS AND COMPOUNDS FOR THE TREATMENT OF FRAGILE X
#7382ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO INCREASE TUMOR KILLING
#7383VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
#7384VIRAL VACCINE COMPOSITIONS AND METHODS OF PREPARATIONS THEREOF
#7385Cancer prevention and therapy by inhibiting soluble tumor necrosis factor
#7386COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION
#7387TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#7388INTERFERON-BASED DISEASE TREATMENT METHOD
#7389Saposin-A derived peptides and uses thereof
#7390Compositions and Methods for Gene Therapy for Corneal Endothelium Disorders
#7391Methods for the prevention or treatment of heart failure
#7392TREATMENTS FOR CANCERS HAVING KRAS MUTATIONS
#7393ATOPIC DERMATITIS THERAPY WITH KAPPA OPIOID RECEPTOR AGONIST AS ADJUNCT TO TOPICAL CORTICOSTEROID
#7394TREATMENT OF CANCER HARBORING MUTATIONS IN THE TP53 GENE AND/OR POST-TRANSLATIONAL MODIFICATIONS IN THE P53 PROTEIN WITH PARVOVIRUSES
#7395VIRAL VECTORS FOR TREATING PARKINSON'S DISEASE
#7396Compositions and methods for treating viral infection
#7397THROMBOSOMES AS AN ANTIPLATELET AGENT REVERSAL AGENT
#7398METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY
#7399PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#7400PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#7401PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#7402MINERAL CATION COMPLEX COMPOSITIONS, FORMULATIONS THEROF, AND METHODS OF USE THEROF
#7403COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF
#7404TREATMENT OF CORONAVIRUS INFECTIONS WITH AURANOFIN
#7405METHODS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER
#7406Pharmaceutical composition, methods for treating and uses thereof
#7407SPIROINDOLONE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
#7408USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RETT SYNDROME
#7409USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#7410USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MUTATIONS IN THE SYNGAPI GENE
#7411USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#7412USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#7413Methods for the Prevention and Treatment of Hearing Loss
#7414Methods for the Prevention and Treatment of Hearing Loss
#7415Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melanin
#7416METHODS OF TREATING HEAVY MENSTRUAL BLEEDING
#7417METHODS OF TREATING PULMONARY INJURY WITH CGRP INHIBITORS
#7418PHARMACEUTICAL RESINATE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#7419COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY
#7420Dizocilpine derivatives as peripheral NMDA receptor antagonists
#7421Anti-Viral Compounds
#7422Methods of treating post-COVID condition(s)
#7423SPIRO-LACTAM COMPOUNDS, PROCESS AND USES THEREOF
#7424Combination comprising a glucocorticoid and EDO-S101
#7425GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER
#7426METHODS FOR TREATING HETEROTOPIC OSSIFICATION
#7427Dihydromyricetin Hot Melt Extrusion Formulations and Methods for Forming Them
#7428Combination methods and compositions including sleep therapeutics for treating mood
#7429Neprilysin inhibitors
#7430Topical anesthetics
#7431Compositions and methods for treating metabolic disorders
#7432COMPOSITION AND METHODS FOR THE TREATMENT OF PERIPHERAL NERVE INJURY
#7433METHOD FOR PRODUCING A LIPOSOME DISPERSION
#7434COMBINED PHARMACEUTICAL FORMULATION COMPRISING GEMCITABINE-CONTAINING LIPOSOME COMPOSITION AND IMMUNE CHECKPOINT INHIBITOR
#7435PHARMACEUTICAL FORMULATIONS COMPRISING TADALAFIL
#7436Implantable Medical Device for the Delivery of Aromatase Inhibitor
#7437VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS
#7438Methods Of Treating Headaches And Migraines With Sodium Voltage-Gated Channel Alpha Subunit 11 (SCN11A) Inhibitors
#7439ANTI-TETRODOTOXIN ANTIBODY C31K8, AND PREPARATION METHOD AND USE THEREOF
#7440ANTI-TETRODOTOXIN ANTIBODY K548, AND PREPARATION METHOD AND USE THEREOF
#7441Anti-CD73 antibodies and use thereof
#7442ANTI-CD137 ANTIBODIES
#7443ANTI-TIGIT ANTIBODIES AND METHODS OF USE
#7444VEGF/DLL4 BINDING AGENTS AND USES THEREOF
#7445Methods and Treatment for Adult-Onset Still's Disease and Systemic-Onset Juvenile Idiopathic Arthritis Involving Antibodies to IL-18
#7446Broadly-Neutralizing HIV Antibodies
#7447ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF
#7448METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#7449Neuroactive steroids, compositions, and uses thereof
#7450Compositions and methods for treating CNS disorders
#7451TRIAZINE COMPOUND AND COMPOSITION AND USE THEREOF
#7452POLYMORPHS OF A GABAA ALPHA5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT
#7453Compounds and methods for treatment of viral infections
#7454HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS
#7455INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER
#7456Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#7457Tetrahydrobenzoazepinones and Related Analogs for Inhibiting YAP/TAZ-TEAD
#7458TRICYCLIC HETEROCYCLES
#7459Disinfectant Composition with Rapid Antiviral Efficacy
#7460USES OF UROLITHINS
#7461USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB
#7462USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB
#7463METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#7464FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS
#7465Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)
#7466Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof
#7467THERAPEUTIC TARGETING OF PHOSPHATE DYSREGULATION IN CANCER VIA THE XPR1:KIDINS220 PROTEIN COMPLEX
#7468BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN
#7469Edible oil compositions to treat oral complications and methods of using same
#7470Boysenberry, apple, and blackcurrant compositions and methods of preparation and use therefor
#7471COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
#7472TREATMENT OF PRIMARY AND/OR SECONDARY LUNG TUMORS USING GASEOUS NITRIC OXIDE INHALATION
#7473ORAL DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AND OTHER NUTRITIONAL SUPPLEMENTS
#7474Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes
#7475Treatment of hearing loss
#7476Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
#7477METHOD OF TREATMENT FOR PSILOCYBIN OR PSILOCIN INFUSION
#7478BROAD SPECTRUM ANTIVIRAL AND METHODS OF USE
#7479Compositions and Methods for the Treatment of Inflammation in Urological Pathology
#7480PHARMACEUTICAL KITS AND THEIR USE FOR TREATING DRY EYE DISEASE
#7481AGENT FOR SUPPRESSING POST-SURGICAL CANCER RECURRENCE AND/OR METASTASIS
#7482COMPOSITIONS FOR LOCAL BONE FORMATION
#7483COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH ELEVATED ARGININE VASOPRESSIN LEVELS
#7484METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#7485METHODS FOR TREATING VASCULAR MALFORMATIONS
#7486Kinase mutation-associated neurodegenerative disorders
#7487Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
#7488COMPOSITIONS AND METHODS TO REDUCE PATHOGENESIS
#7489METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#7490COMPOSITIONS COMPRISING ATICAPRANT
#7491COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS
#7492TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#7493DIETARY PRODUCT DEVOID OF AT LEAST TWO NON ESSENTIAL AMINO ACIDS
#7494INTERMEDIATE METABOLISM PRODUCTS TO POTENTIATE AMINOGLYCOSIDE ANTIBIOTICS IN BACTERIAL INFECTIONS
#7495DRUG COMBINATION AND ITS USE IN THE TREATMENT OF CANCER
#7496Methods for the treatment of lysosomal storage diseases
#7497Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#7498ANTIDIABETIC PHARMACEUTICAL COMPOSITIONS
#7499ORAL CAVITY POLYMERIC DELIVERY SYSTEMS
#7500TARGETED RELEASE RIFAXIMIN COMPOSITIONS